Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Glomerular disease

Sugars and immune complex formation in IgA nephropathy

In vitro evidence suggests that immune complex formation in IgA nephropathy is determined by the sugar content of the IgA1 hinge region. Absence of galactose residues in this region renders the IgA1 molecule immunogenic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Barratt, J., Smith, A. C., Molyneux, K. & Feehally, J. Immunopathogenesis of IgAN. Semin. Immunopathol. 29, 427–443 (2007).

    Article  CAS  PubMed  Google Scholar 

  2. Novak, J., Julian, B. A., Tomana, M. & Mestecky, J. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin. Nephrol. 28, 78–87 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Suzuki, H. et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119, 1668–1677 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Bonner, A., Furtado, P. B., Almogren, A., Kerr, M. A. & Perkins, S. J. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy. J. Immunol. 180, 1008–1018 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. Allen, A. C. et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 60, 969–973 (2001).

    Article  CAS  PubMed  Google Scholar 

  6. Gharavi, A. G. et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 19, 1008–1014 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Smith, A. C., Molyneux, K., Feehally, J. & Barratt, J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J. Am. Soc. Nephrol. 17, 3520–3528 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. Harper, S. J., Allen, A. C., Pringle, J. H. & Feehally, J. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J. Clin. Pathol. 49, 38–42 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Novak, J. et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 67, 504–513 (2005).

    Article  CAS  PubMed  Google Scholar 

  10. Moldoveanu, Z. et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 71, 1148–1154 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Barratt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barratt, J., Eitner, F. Sugars and immune complex formation in IgA nephropathy. Nat Rev Nephrol 5, 612–614 (2009). https://doi.org/10.1038/nrneph.2009.165

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.165

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing